Panel: Why Are We Not Doing Better? An Open Discussion of the Limitations of Current Drug Development for GBM and Where the Field Can Improve

Time: 9:25 am


  • Barriers to advancing drug development and strategies to address these
  • Major therapeutic strategies currently under development
  • How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?